弗格森埃希菌的流行及耐药性研究进展

弗格森埃希菌是与大肠埃希菌同属近源的人畜共患条件致病菌。自1985年被发现并命名以来,已有多项研究表明弗格森埃希菌具有多重耐药性,可能是被忽视的重要的耐药基因储藏库。本文对弗格森埃希菌现有的研究进展进行综述,包括弗格森埃希菌的特征、鉴定方法、流行情况、致病性和毒力、耐药性,以便更好地了解弗格森埃希菌在人类和动物疾病感染中所扮演的角色,作好弗格森埃希菌的预防和治疗工作。     

空肠弯曲菌感染动物模型的研究进展

空肠弯曲菌是一种全球关注的人兽共患病原菌,感染后可引起人和动物多种疾病。动物模型是开展致病机理、疫苗评价和药物开发等研究的基础。空肠弯曲菌由于培养条件苛刻以及感染实验动物的疾病相似性、经济性和重复性等因素,仍缺乏良好的感染动物模型,其致病机理迄今尚不清楚。本文对已报道的空肠弯曲菌感染实验动物模型进行综述。     

多囊卵巢综合征患者肠道菌群和生化免疫分子特征

【目的】比较多囊卵巢综合征(polycysticovariansyndrome,PCOS)患者与健康对照间肠道菌群谱结构特征差异,并探讨多囊卵巢综合征患者差异菌群与生化免疫指标之间的联系。【方法】选取初诊多囊卵巢综合征患者23例和健康女性对照23例,每例患者于初诊时留取粪便标本和血液标本,粪便标本提取DNA进行宏基因组测序,血清用于检测性激素和炎症因子。通过生物信息分析比较多囊卵巢综合征患者与健康对照间肠道菌群谱结构特征差异,以及与相关指标的联系。【结果】发现多囊卵巢综合征患者与健康对照的肠道菌群在门、属、种水平均有明显差异。两组间差异菌种为4个,普通拟杆菌(Bacteroides vulgatus)和弗格森埃希菌(Escherichia fergusonii)在PCOS组中的相对丰度高于对照组,并且这两种菌与PCOS的发病机制密切相关。凸腹真杆菌(Eubacteriumventriosum)和Subdoligranulum unclassified菌的相对丰度低于健康对照组。其中普通拟杆菌、凸腹真杆菌和Subdoligranulum unclassified菌3个菌种彼此间存在相关性...     

沙门菌毒力岛引发持续性感染机制的研究进展

沙门菌是一种重要的人兽共患食源性病原菌。其感染宿主后可以凭借独特的免疫逃逸机制逃避宿主免疫系统的清除,潜伏在宿主体内1年至终身不等,从而建立持续性感染。沙门菌持续性感染与毒力岛密切相关,尤其是沙门菌毒力岛（Salmonella pathogenicity islands,SPIs） SPI-1和SPI-2。SPI-1效应蛋白SipB和SipC等以不同的途径影响细菌入侵,诱导细胞自噬或者凋亡;而SPI-2效应蛋白SseI和SseL等可以通过调控不同的信号通路协助沙门菌的胞内存活,为沙门菌持续性感染的发生和发展提供条件。本文主要阐述SipB和SseI等毒力岛效应蛋白在沙门菌持续性感染过程中的作用,同时总结了SPI-6、SPI-7和SPI-19等毒力岛的作用,以期为研究沙门菌持续性感染提供新思路。     

应用绿色荧光蛋白标记迟缓爱德华菌感染斑马鱼

目的建立斑马鱼模型研究迟缓爱德华菌的致病性及感染途径。方法应用绿色荧光蛋白标记迟缓爱德华菌,追踪观察其感染斑马鱼的动力学过程及病理组织学变化。结果病理组织学检查以肝脏水肿变性,肝细胞萎缩、坏死、脱落,脾脏散在增生性结节、充血、水肿、淋巴细胞大量缺失等病变为主;感染后,该菌先后在斑马鱼肠道、鳃和皮肤中定植。结论斑马鱼可作为研究迟缓爱德华菌致病性的动物模型。肠道、鳃和皮肤可能是迟缓爱德华菌先后感染斑马鱼的主要途径。     

规模化养殖条件下生猪肠道微生物资源分离和鉴定

肠道微生物作为机体的重要组成部分,与生猪健康密切相关。为了获取生猪肠道微生物资源,本研究同时采用有氧分离和厌氧分离技术,从12份新鲜猪粪便中分离获得174株细菌。通过16S rRNA基因比对分析对菌株进行初步鉴定后发现,有氧分离条件下获取的105株细菌隶属于8个科、13个属和19个种,其中以弗格森埃希氏杆菌（Escherichia fergusonii）居多;厌氧条件下获取的69株细菌隶属于7个科,13个属,20个种,大部分是福氏志贺氏菌（Shigella flexneri）和弗格森埃希氏杆菌（Escherichia fergusonii）;其中,潜在益生菌株28株,包括粪肠球菌（Enterococcus faecalis）、河流漫游球菌（Vagococcus fluvialis）和乳酸乳球菌（Lactococcus lactis）。本研究有助于加深对生猪肠道可培养微生物资源和微生物生态的认识,为肠道微生态和动物益生菌的进一步研究和应用提供优良菌种资源。     

住院患者多重耐药菌感染临床研究

目的 探讨住院患者多重耐药菌感染情况与病原学特点,为临床制定医院感染控制措施提供参考依据.方法 对住院患者中的多重耐药菌感染及病原特点情况进行统计分析.结果 住院患者多重耐药菌感染发生率为3.5％,主要为革兰阴性菌(71.5％),多重耐药菌居前7位的依次是大肠埃希菌、肺炎克雷伯菌、鲍曼不动杆菌、铜绿假单胞菌、凝固酶阴性葡萄球菌、肠球菌属、金黄色葡萄球菌等.多重耐药菌感染的患者主要来自于重症监护室、神经外科、呼吸内科等.多重耐药菌对选用的抗生素均有较高的耐药性.结论 多重耐药菌耐药率普遍较高,临床医师应重视病原学检查及药敏监测,合理选择使用抗菌药物.     

皮肤癣菌病发病机制研究进展

皮肤癣菌病是由皮肤癣菌引起的角化组织感染（皮肤、毛发和甲）,是人群中发病率最高的感染性皮肤病。在皮肤癣菌感染皮肤过程中,蛋白水解酶是皮肤癣菌的主要毒力因子,这种酶需要在合适的pH及温度下才能发挥它的活性而致病;而机体是否被感染则取决于宿主的皮肤机械屏障功能、免疫反应等。     

院内感染复数菌败血症的临床和耐药分析

目的 探讨院内感染复数菌败血症的临床特征、危险因素、致病菌分布及耐药情况。方法 回顾性分析1970～2004年经血培养和临床资料证实的126例院内感染的复数菌败血症。结果 院内感染复数菌败血症均发生在较严重的基础疾病上．创伤性手术和操作、广谱抗菌药物和免疫抑制剂的应用、放疗与化疗为该病的危险因素。院内感染复数菌败血症感染病死率达52％,致病菌以G^-菌占多数,合并真菌感染者死亡率高。致病菌多为耐药菌株。结论 院内感染复数菌败血症病情危重,病死率高,多系耐药菌株感染。应尽早治疗原发基础疾病,避免危险因素,严格掌握侵入性诊疗手段的运用指征,合理应用抗菌药物。并重视院内环境卫生,严格做好洗手、消毒等是防止耐药菌播散的主要措施。     

医院空气中细菌与临床感染的关系研究

医院感染已列为国家质量管理的一个重要组成部分,感染菌的来源,主要分内源性菌,即患者自身带的菌又感染了自己。另一种是外源性菌,即外环境包括空气中的细菌、各种物品中的细菌、人员接触等。医院内感染;以呼吸道感染占首位(59％),空气传播是引起感染的重要方面,空气中病原性微生物的污染程度直接决定感染率的高低。为了弄清医院空气中菌群分布情况及从空气中和临床患者中分离出同一类菌的关系,进行了对比实验及耐药性分析,现将结果报告如下。     

Prion infection

The prion infection is a conversion of host encoded prion protein (PrP) from its cellular isoform PrPC into the pathological and infectious isoform PrPSc; the conversion process was investigated by in vitro studies using recombinant and cellular PrP and natural PrPSc. We present a brief summary of the results determined with our in vitro conversion system and the derived mechanistic models. We describe well characterized intermediates and precursor states during the conversion process, kinetic studies of spontaneous and seeded fibrillogenesis and the impact of the membrane environment.     

Glutathione and infection

Background

The tripeptide γ-glutamylcysteinylglycine or glutathione (GSH) has demonstrated protective abilities against the detrimental effects of oxidative stress within the human body, as well as protection against infection by exogenous microbial organisms.

Scope of review

In this review we describe how GSH works to modulate the behavior of many cells including the cells of the immune system, augmenting the innate and the adaptive immunity as well as conferring protection against microbial, viral and parasitic infections. This article unveils the direct antimicrobial effects of GSH in controlling Mycobacterium tuberculosis (M. tb) infection within macrophages. In addition, we summarize the effects of GSH in enhancing the functional activity of various immune cells such as natural killer (NK) cells and T cells resulting in inhibition in the growth of M. tb inside monocytes and macrophages. Most importantly we correlate the decreased GSH levels previously observed in individuals with pulmonary tuberculosis (TB) with an increase in the levels of pro-inflammatory cytokines which aid in the growth of M. tb.

Major conclusions

In conclusion, this review provides detailed information on the protective integral effects of GSH along with its therapeutic effects as they relate to the human immune system and health.

General significance

It is important to note that the increases in the levels of pro-inflammatory cytokines are not only detrimental to the host due to the sequel that follow such as fever and cachexia, but also due to the alteration in the functions of immune cells. The additional protective effects of GSH are evident after sequel that follows the depletion of this antioxidant. This is evident in a condition such as Cystic Fibrosis (CF) where an increased oxidant burden inhibits the clearance of the affecting organism and results in oxidant-induced anti-protease inhibition. GSH has a similar protective effect in protozoans as it does in human cells. Thus GSH is integral to the survival of some of the protozoans because some protozoans utilize the compound trypanothione [T(SH)₂] as their main antioxidant. T(SH)₂ in turn requires GSH for its production. Hence a decrease in the levels of GSH (by a known inhibitor such as buthionine sulfoximine [BSO] can have adverse effects of the protozoan parasites. This article is part of a Special Issue entitled Cellular functions of glutathione.     

Burkholderia cenocepacia infection

Phagocytosis is an important component of innate immunity that contributes to the eradication of infectious microorganisms; however, successful bacterial pathogens often evade different aspects of host immune responses. A common bacterial evasion strategy entails the production of toxins and/or effectors that disrupt normal host cell processes and because of their importance Rho-family GTPases are often targeted. Burkholderia cenocepacia, an opportunistic pathogen that has a propensity to infect cystic fibrosis patients, is an example of a pathogenic bacterium that has only recently been shown to disrupt Rho GTPase function in professional phagocytes. More specifically, B. cenocepacia disrupts Rac and Cdc42 seemingly through perturbation of guanine nucleotide exchange factor function. Inactivation of Rac, Cdc42 and conceivably other Rho GTPases seriously compromises phagocyte function.     

Bacteriophage secondary infection

Virologica Sinica - Phages are credited with having been first described in what we now, officially, are commemorating as the 100th anniversary of their discovery. Those one-hundred years of phage...